PMVP, PMV Pharmaceuticals, Inc

"Loading Stock Price & Valuation Data ..."

Agentic AI (Pro) Picks for PMVP

Subscribe to iPick.ai (Pro) to use Power Picks, Hidden-Gem Picks, and more.


News Summary: Subscribe

Unlock News Summary by Subscribing to iPick.ai Premium!





Unlock Ask PMVP by Subscribing to iPick.ai Premium!



Stock Chart




Latest YouTube Video:



CEO:Dr. David H. Mack Ph.D.

Headquarter: 400 Alexander Park Drive, Suite 301, Princeton, NJ, United States, 08540

Industry: Biotechnology,   Investment Track: -,   Employees: 54

Business Summary

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States. It develops rezatapopt, a selective structural corrector of p53 Y220C mutations in Phase 2 clinical trials for tumor agnostic diseases. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Princeton, New Jersey.